US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
US6974590B2
(en)
*
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6462030B1
(en)
*
|
1999-07-19 |
2002-10-08 |
New York Blood Center, Inc. |
Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methycellulose phthalate
|
US6251136B1
(en)
*
|
1999-12-08 |
2001-06-26 |
Advanced Cardiovascular Systems, Inc. |
Method of layering a three-coated stent using pharmacological and polymeric agents
|
BRPI0109078B8
(pt)
|
2000-03-07 |
2021-05-25 |
Rush Presbyterian St Lukes Medical Center |
composição antimicrobiana e contraceptiva que reduz o risco de transmissão ou infecção por doença sexualmente transmitida através de atividade sexual
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
US6537538B2
(en)
|
2000-12-18 |
2003-03-25 |
Rush-Presbyterian-St. Luke's Medical Center |
Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate
|
KR100392363B1
(ko)
*
|
2000-12-26 |
2003-07-22 |
한국전자통신연구원 |
형광체 및 그 제조방법
|
CN1259049C
(zh)
*
|
2001-07-06 |
2006-06-14 |
苏坎波公司 |
包含白介素-2抑制剂和抗菌剂的局部给药组合物
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
MXPA05004278A
(es)
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
AU2003276254A1
(en)
*
|
2002-11-05 |
2004-06-07 |
Piero Chiarelli |
Controlled and continued delivery of rifaximin and/or other substances
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
WO2004110461A1
(en)
*
|
2003-06-13 |
2004-12-23 |
Idh Holding Aps |
Treatment of symptoms associated with bacterial vaginosis
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US20060140990A1
(en)
*
|
2003-09-19 |
2006-06-29 |
Drugtech Corporation |
Composition for topical treatment of mixed vaginal infections
|
BRPI0414500A
(pt)
*
|
2003-09-19 |
2006-11-07 |
Drugtech Corp |
formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
|
WO2005065317A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Effervescent oral fentanyl dosage form
|
ATE498395T1
(de)
*
|
2003-12-31 |
2011-03-15 |
Cima Labs Inc |
Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
|
CA2549642C
(en)
*
|
2003-12-31 |
2012-10-30 |
Cima Labs Inc. |
Effervescent oral opiate dosage forms and methods of administering opiates
|
WO2005085287A1
(en)
*
|
2004-03-03 |
2005-09-15 |
En-N-Tech, Inc. |
Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
ES2522895T3
(es)
|
2005-03-03 |
2014-11-19 |
Alfa Wassermann S.P.A. |
Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
MX2007013631A
(es)
*
|
2005-05-09 |
2008-01-24 |
Drugtech Corp |
Composiciones farmaceuticas de liberacion modificada.
|
EP1893396A2
(en)
*
|
2005-05-09 |
2008-03-05 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US20070154516A1
(en)
*
|
2006-01-05 |
2007-07-05 |
Drugtech Corporation |
Drug delivery system
|
US20070224226A1
(en)
*
|
2006-01-05 |
2007-09-27 |
Drugtech Corporation |
Composition and method of use thereof
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
WO2008106646A2
(en)
*
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
EP2837378A1
(en)
*
|
2007-07-06 |
2015-02-18 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
AU2016203925B2
(en)
*
|
2007-07-06 |
2016-10-20 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
WO2009008005A1
(en)
*
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
CA2712120A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
CN102164599B
(zh)
|
2008-09-26 |
2014-07-23 |
Aska制药株式会社 |
预防和/或治疗功能性胃肠障碍的药剂
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
CA2776474C
(en)
|
2009-10-02 |
2021-01-12 |
Foamix Ltd. |
Topical tetracycline compositions
|
EP2493456B1
(en)
*
|
2009-10-27 |
2018-11-21 |
Lupin Limited |
Solid dispersion of rifaximin
|
KR20120099731A
(ko)
*
|
2009-11-23 |
2012-09-11 |
시플라 리미티드 |
국소용 폼 조성물
|
RU2012126084A
(ru)
*
|
2009-11-23 |
2013-12-27 |
Сипла Лимитед |
Пенная композиция для местного применения
|
US7888062B1
(en)
|
2010-02-01 |
2011-02-15 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
US8445226B2
(en)
|
2010-02-01 |
2013-05-21 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
WO2012076832A1
(en)
|
2010-12-09 |
2012-06-14 |
Cipla Limited |
Suppositories comprising rifaximin
|
ITBO20110461A1
(it)
*
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
CN102512358B
(zh)
*
|
2011-12-16 |
2013-04-10 |
南京农业大学 |
家畜用利福昔明阴道栓剂及其制备方法
|
US20160038468A1
(en)
*
|
2013-03-15 |
2016-02-11 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
US20160047819A1
(en)
|
2013-03-15 |
2016-02-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
KR102362719B1
(ko)
|
2014-05-12 |
2022-02-14 |
알파시그마 에스.피.에이. |
리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도
|
CA2959414C
(en)
|
2014-09-05 |
2023-03-14 |
Symbiomix Therapeutics, Llc |
Secnidazole for use in the treatment of bacterial vaginosis
|
PL3261683T3
(pl)
*
|
2015-02-26 |
2019-08-30 |
Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol |
Kompozycja do stosowania miejscowego do leczenia uszkodzeń błony śluzowej
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
US20190008784A1
(en)
*
|
2017-07-07 |
2019-01-10 |
Symbiomix Therapeutics, Llc |
Novel secnidazole soft gelatin capsule formulations and uses thereof
|
WO2019073321A1
(en)
*
|
2017-10-10 |
2019-04-18 |
Zenvision Pharma Llp |
EFFERVESCENT COMPOSITIONS COMPRISING RIFAXIMINE
|
US20230398102A1
(en)
*
|
2020-10-29 |
2023-12-14 |
Bausch Health Ireland Limited |
Rifaximin liquid formulations for use inthe treatment of sickle cell disease
|